Henry Ford Pharmacology Practice Test

Hypoglycemia is a well-known side effect associated with oral hypoglycemic agents, particularly those that stimulate insulin secretion from the pancreas, such as sulfonylureas and meglitinides. These medications can lower blood glucose levels effectively, but they also carry the risk of causing blood glucose levels to drop too low, leading to symptoms such as shakiness, sweating, confusion, and in severe cases, loss of consciousness.

The mechanism behind hypoglycemia involves the enhancement of insulin secretion without the appropriate balancing of dietary intake or glucose production. Therefore, monitoring blood glucose levels and patient education about recognizing the signs of hypoglycemia are critical components of managing therapy with these agents.

In contrast, other potential side effects like diarrhea or weight gain may occur with specific medications but are not as universally recognized across all types of oral hypoglycemics compared to hypoglycemia. Hypertension is typically not a direct side effect of oral hypoglycemic agents and generally is not associated with their action. Thus, hypoglycemia stands out as a common and significant concern when prescribing these medications.